Skip to main content

Table 3 Clinical outcomes in patients with moderate preoperative symptoms

From: A prospective cohort study: platelet-rich plasma combined with carpal tunnel release treating carpal tunnel syndrome

 

Control Group

N = 26

PRP Group

N = 26

P

*Significant

VAS preoperative

4.00 ± 1.07

3.84 ± 1.16

0.630

VAS 1 month following surgery

2.42 ± 1.30

1.69 ± 0.66

0.016*

VAS 3 months following surgery

1.12 ± 0.93

1.00 ± 0.83

0.647

VAS 6 months following surgery

0.46 ± 0.69

0.42 ± 0.63

0.838

BCTQ-SSS preoperative

2.36 ± 0.41

2.41 ± 0.43

0.701

BCTQ-SSS 1 month following surgery

1.90 ± 0.54

1.57 ± 0.35

0.016*

BCTQ-SSS 3 months following surgery

1.25 ± 0.51

1.06 ± 0.48

0.201

BCTQ-SSS 6 months following surgery

0.80 ± 0.67

0.66 ± 0.61

0.438

BCTQ-FSS preoperative

2.42 ± 0.58

2.51 ± 0.41

0.521

BCTQ-FSS 1 month following surgery

1.83 ± 0.57

1.54 ± 0.37

0.037*

BCTQ-FSS 3 months following surgery

1.33 ± 0.56

1.29 ± 0.45

0.773

BCTQ-FSS 6 months following surgery

0.95 ± 0.73

0.87 ± 0.53

0.659

Grip strength preoperative (g/mm2)

19.47 ± 3.71

18.68 ± 4.36

0.470

Grip strength 1 month after surgery(g/mm2)

20.86 ± 3.53

20.44 ± 4.41

0.710

Grip strength 3 months after surgery (g/mm2)

23.19 ± 4.06

23.21 ± 4.87

0.983

Grip strength 6 months after surgery(g/mm2)

24.79 ± 4.04

26.25 ± 5.79

0.303

  1. *Represents a statistical difference between two groups (p < 0.05)